Part n nI: nn Basic nn Immunologic nn Mechanisms
1. Highlights n n of nn Innate nn and n n Adaptive nn Immune nnSystems
2. Soluble n n Mediators n n of n n the nn Immune nnSystem
3. Antigens n n and n nAntibodies
4. Cellular nn Activities nn and n n Clinical n n Disorders n n of n n Innate n nand n n Adaptive n n Immunity
Part n n II: n nThe n n Theory n n of n n Immunologic n n and n n Serologic nnProcedures
5. Basic nn Safety nn in nn the nn Immunology-Serology nn Laboratory
6. Quality n nAssurance nn and nn Quality nn Control n nPractices
7. Basic nn Serologic nn Laboratory: nn Techniques n n and nn Clinical n n Applications
8. Precipitation nn and nn Particle nn Agglutination nn Methods
9. Electrophoresis nn Techniques
10. Labeling nn Techniques nn in nn Immunoassay
11. Flow nnCytometry
12. Molecular n n Laboratory n n Techniques
Part n n III: n n Immunologic n n Manifestations nn of nn Infectious nn Diseases
13. Infectious nn Diseases: n n Overview nn & nn TORCH nn Diseases
14. Streptococcal nn Infections
15. Syphilis
16. Vector-Borne nn Diseases
17. Infectious nn Mononucleosis
18. Viral n n Hepatitis
Part n nIV: n n Immune nn Disorders
19. Primary nn and nn Acquired nn (Secondary) nn Immune nn Deficiencies
20. Hypersensitivity nn Reactions
21. Immunoproliferative nn Disorders
22. Tolerance, nn Autoimmunity nn and nn Autoimmune nn Disorders
23. Systemic nn Lupus nn Erythematosus
,24. Rheumatoid n n Arthritis
Part n nV: n n Transplantation nn & n nTumor nn Immunology
25. Transplantation: nn HLA, nn Solid n n Organ, n n and nn Hematopoietic nn Stem nn Cells
26. Tumor n n Immunology n nand nn Up-to-Date nn Applications n n of nn Next n n Generation nn Sequencing
Part nnVI: n n Vaccines
27. Primer nnon nn Vaccines
Chapter 01: Highlights of the Innate and Adaptive Immune Systems
nn nn nn nn nn nn nn nn nn
MULTIPLE nnCHOICE
1. The nn―father‖ nnof nnimmunology nnis nngenerally nnconsidered nnto nnbe
a. Koch.
b. Pasteur.
c. Gram.
d. Salk.
ANS: n n B
, Louis nnPasteur nnis nngenerally nnconsidered nnto nnbe nnthe nn―father nnof nnimmunology.‖
DIF: Cognitive nnLevel: nnI
2. An nnearly nnform nnof nnimmunization nnwas nnpracticed nnby nnthe
a. Romans.
b. Greeks.
c. Chinese.
d. Native nnAmericans.
ANS: n n C
Beginning nnabout nn1000 nnAD, nnthe nnChinese nnpracticed nna nnform nnof nnimmunization nnby nninhaling
nndried nnpowders nnderived nnfrom nnthe nncrusts nnof nnsmallpox nnlesions.
DIF: Cognitive nnLevel: nnI
3. A nnspecific nn function nnof nnthe nnimmune nnsystem nnis nnto
a. recognize nnself nnfrom nnnonself.
b. defend nnthe nnbody nnagainst nn nonself.
c. amplify nnspecific nnfunctions.
d. Both nnA nnand nnB.
ANS: n n D
The nnfunction nnof nnthe nnimmune nnsystem nnis nnto nnrecognize nnself nnfrom nnnonself nnand nndefend
nnthe nnbody nnagainst nnnonself. nnSuch nna nnsystem nnis nnnecessary nnfor nnsurvival. nnThe nnimmune
nnsystem nnalso nnhas nnnonspecific nneffector nnmechanisms nnthat nnusually nnamplify nnthe nnspecific
nnfunctions. nnNonspecific nncomponents nnof nnthe nnimmune nnsystem nninclude nnmononuclear
nnphagocytes, nnpolymorphonuclear nnleukocytes, nnand nnsoluble nnfactors nn(e.g., nncomplement).
DIF: Cognitive nnLevel: nnI
4. An nnundesirable nnconsequence nnof nnimmunity nnis
a. natural nnresistance.
b. acquired nnresistance nnto nninfectious nndiseases.